← FDA Drug Approvals (Drugs@FDA)
RASAGILINE MESYLATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CARNEGIE · Approved 2021-11-18
Drug application
- FDA Application #
ANDA201942- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RASAGILINE MESYLATE
- Generic name
- RASAGILINE MESYLATE
- Active ingredients
- RASAGILINE MESYLATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CARNEGIE
- Manufacturer
- Carnegie Pharmaceuticals LLC
- First approval
- 2021-11-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown